News and Insights

8.21.25

210 Dykema Lawyers Listed in The Best Lawyers in America® 2026 and Best Lawyers “Ones to Watch”

Dykema, a leading national law firm, announced today that 210 of its attorneys, in multiple practice areas and markets, have been recognized in The Best Lawyers in America® 2026 guide and the Best…

3.03.25

Dykema Advises Wellgistics Health, Inc. on Nasdaq IPO

Congratulations to Dykema’s client, Wellgistics Health, Inc. (Nasdaq: WGRX), on the successful completion of its initial public offering (IPO). Wellgistics’ common stock began trading on the Nasdaq…

2.27.25

Dykema Advises PowerUp Acquisition Corp. in Aspire Biopharma’s Nasdaq Listing

Congratulations to Dykema’s client, PowerUp Acquisition Corp., in its successful business combination with Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP), a developer of patent-protected disruptive…

4.26.22

SPAC, IPO or Private Equity: Which Exit Fits, and Are You Ready?

Kate Bechen participated in the American Health Law Association’s Health Care Transactions 2022 program on April 26, 2022. Bechen’s session, “SPAC, IPO or Private Equity: Which Exit Fits, and Are You…